Join Growin Stock Community!

啟弘生技6939.TW Overview

TW StockBiotech. & Medical
(No presentation for 6939)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

啟弘生技（6939）Overall Performance

啟弘生技（6939）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

啟弘生技（6939） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

啟弘生技（6939）Key Information

啟弘生技（6939）Profile

TFBS Bioscience Inc., a contract research organization, provides biological testing services in Taiwan. It offers viral vector manufacturing services for cell and gene therapy products; and biosafety testing and product release testing for cell and gene therapy products, vaccines, and biologic products. The company was incorporated in 2016 and is headquartered in New Taipei City, Taiwan.

啟弘生技（6939）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

No related data records

default symbol

6939

啟弘生技

19.95D

1.25%

(0.01)

  • When is 6939's latest earnings report released?

    The most recent financial report for 啟弘生技 (6939) covers the period of 2025Q2 and was published on 2025/06/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 6939's short-term business performance and financial health. For the latest updates on 6939's earnings releases, visit this page regularly.

  • How much cash does 6939 have?

    At the end of the period, 啟弘生技 (6939) held Total Cash and Cash Equivalents of 388.87M, accounting for 0.26 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 6939 go with three margins increasing?

    In the latest report, 啟弘生技 (6939) did not achieve the “three margins increasing” benchmark, with a gross margin of 23.99%%, operating margin of -48.17%%, and net margin of -45.9%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 6939's profit trajectory and future growth potential.